Graphic: 7 Biosimilars OK’d by FDA

The U.S. Food and Drug Administration to date has approved seven biosimilars, including Zarxio, Inflectra and Erelzi.

A rundown on the seven biosimilars can be seen at left.

(Graphic courtesy of Center for Biosimilars)